Inconsistent definitions of radical resection in perioperative trials of non-small cell lung cancer: a scoping review
Open Access
- 1 June 2026
- journal article
- review article
- Published by AME Publishing Company in Translational Lung Cancer Research
- Vol. 15 (6) , 182
Abstract
Background: Perioperative therapies have altered curative-intent treatment for resectable non-small cell lung cancer (NSCLC). Nonetheless, radical resection (R0) still remains one of the most vital determinants of the final clinical outcome. This study evaluates the definition of radical resection across perioperative NSCLC trials in the context of the National Comprehensive Cancer Network (NCCN) and International Association for the Study of Lung Cancer (IASLC) guidelines. Methods: A scoping review in accordance with PRISMA-ScR 2018 guidelines was conducted to identify suitable clinical trial protocols. PubMed and ClinicalTrials.gov were searched for trials published between 2020 and 2025, focusing on studies with full protocols in English that included surgical treatment of NSCLC. Surgical radicality and lymphadenectomy definitions provided in the protocols were extracted and evaluated for adherence to NCCN and IASLC guidelines. Each component was assigned a value of ‘1’ if the criterion was met and ‘0’ if it was not. These binary scores were subsequently used to assess the overall compliance with the guidelines. Results: Out of 563 records initially identified, 47 were ultimately included. Only 15% of studies fully met the radical resection criteria according to both the NCCN and IASLC guidelines. As for lymphadenectomy, 30% of studies adhered to the NCCN guidelines, while 15% followed the IASLC guidelines. Conclusions: These findings highlight the persistent lack of a clear and uniform definition of radical resection in NSCLC amongst trial protocols. Such heterogeneity pose difficulty in interpretability and comparability of clinical data. It is of utmost importance to reinforce a trend toward standardization, for the sake of both patients and physicians.Keywords
This publication has 30 references indexed in Scilit:
- Beyond Margin Status: Population-Based Validation of the Proposed International Association for the Study of Lung Cancer Residual Tumor Classification RecategorizationJournal of Thoracic Oncology, 2020
- The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non–Small Cell Lung CancerJournal of Thoracic Oncology, 2020
- PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and ExplanationAnnals of Internal Medicine, 2018
- The 8th TNM edition for lung cancer: a critical analysisAnnals of Translational Medicine, 2018
- Improved Lymph Node Staging in Early-Stage Lung Cancer in the National Cancer DatabaseThe Annals of Thoracic Surgery, 2017
- Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2014
- ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer☆European Journal of Cardio-Thoracic Surgery, 2006
- Complete resection in lung cancer surgery: proposed definitionLung Cancer, 2005
- Residual tumor (R) classification and prognosisSeminars in Surgical Oncology, 1994
- Lymph node mapping and curability at various levels of metastasis in resected lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1978